A comparison of the phenotypic susceptibility profiles of emtricitabine and lamivudine.
about
Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv cohortHighly-sensitive allele-specific PCR testing identifies a greater prevalence of transmitted HIV drug resistance in JapanNovel high-throughput screen identifies an HIV-1 reverse transcriptase inhibitor with a unique mechanism of actionHepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.Comparative Meta-Analysis of Tenofovir Disoproxil Fumarate versus Emtricitabine and Tenofovir Disoproxil Fumarate as Treatments for Patients with Chronic Hepatitis B.Current treatment of HIV/hepatitis B virus coinfection.Prevention of hepatitis B virus infection: from the past to the future.
P2860
Q28477027-B6AED7F3-D1CB-4485-8FD8-3587CD373FD9Q28537608-EF681B40-EF13-4CE1-980D-6F8B1FD3BA50Q28829256-E3A1BC59-A693-49EF-BDAF-19F92DDC00DFQ34405008-AEB33B7C-B8E7-4BEA-AC39-35F7265DD6C7Q35844432-BF41E26E-97EF-4BFC-8850-C733DE3739C8Q37138048-6A242EA1-D14F-4801-82C9-7926F1E55861Q38354222-C0E35AD3-5CE0-4114-803F-958C9B68E0C7
P2860
A comparison of the phenotypic susceptibility profiles of emtricitabine and lamivudine.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A comparison of the phenotypic susceptibility profiles of emtricitabine and lamivudine.
@en
type
label
A comparison of the phenotypic susceptibility profiles of emtricitabine and lamivudine.
@en
prefLabel
A comparison of the phenotypic susceptibility profiles of emtricitabine and lamivudine.
@en
P2093
P2860
P1476
A comparison of the phenotypic susceptibility profiles of emtricitabine and lamivudine.
@en
P2093
Katyna Borroto-Esoda
Michael D Miller
Neil Parkin
P2860
P304
P356
10.1177/095632020701800505
P577
2007-01-01T00:00:00Z